Science & Technology Review
|
2021, 39(1): 144-165
• Exclusive: Science and Technology Review in 2020 •
A review of SARS-CoV-2 in 2020: Molecular pathology and drugs and vaccines in development
Full
YE Sheng
Affiliations
Interdisciplinary Innovation Institute of Medicine & Engineering, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China
Published: 2021-01-13
doi: 10.3981/j.issn.1000-7857.2021.01.012
Outline
Since SARS-CoV-2 was discovered in December 2019, the coronavirus has caused a serious pandernic of severe respiratory infectious disease, which subsequently spread globally. The scientific community reacted immediately to perform comprehensive and exhaustive studies on SARS-CoV-2 and the diseases it caused. Benefited from the knowledge accumulated in previous studies of SARS-CoV and MERS-CoV, the research work of SARS-CoV-2 got extensive achievements in 2020, especially in molecular pathology. Mastering the knowledge has built a solid foundation for the drug and vaccine development against SARS-CoV-2. In this review, the research history of coronaviruses is briefly reviewed, followed by a summary of molecular pathological studies on SARS-CoV-2 in 2020, as well as the progress of drug and vaccine development against SARS-CoV-2.
coronavirus
/
SARS-CoV-2
/
SARS
/
MERS
/
vaccine
YE Sheng.
A review of SARS-CoV-2 in 2020: Molecular pathology and drugs and vaccines in development[J].
Science & Technology Review,
2021
, 39
(1)
: 144
-165
.
DOI: 10.3981/j.issn.1000-7857.2021.01.012
Year 2021 volume 39 Issue 1
PDF
543
135
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2021.01.012
- Receive Date:2021-01-06
- Online Date:2021-03-10
- Published:2021-01-13